Thyroid Gland Nodule clinical trials
13 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
- TRAIL Study: Feasibility and Pilot
- Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
- A Study of Multiparametric Ultrasound Imaging Methods
- Radiofrequency Ablation Study in LatinX Patients
- Studies on Tumors of the Thyroid
- Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
- Radiofrequency Ablation for BIII Thyroid Nodules
- Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
- Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- Decision Aid and Thyroid Nodules Management
- Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
- Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Thyroid Gland Nodule” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.